Medicinova (MNOV) Interest Expenses (2010 - 2026)
Medicinova (MNOV) posted quarterly Interest Expenses of $3000.0 for Q4 2025, down 99.4% year-over-year from $500000.0 in Q4 2024, and down 98.28% quarter-over-quarter from $174427.0 in Q3 2025.
Medicinova (MNOV) Interest Expenses (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Interest Expenses for 16 consecutive years, with $3000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest Expenses fell 99.4% year-over-year to $3000.0; the TTM figure through Dec 2025 stood at $3000.0 (down 99.4% YoY), while the FY2025 annual figure was $81.0 million, up 16104.58% from the prior year.
- Interest Expenses eased to $3000.0 in Q4 2025 per MNOV's latest filing, from $174427.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $83.4 million in Q4 2023 and bottomed at $3000.0 in Q4 2025.
- Historically, Interest Expenses has averaged $4.7 million across 5 years, with a median of $327009.0 in 2025.
- Annual changes were most pronounced in 2021 — Interest Expenses slumped 99.95% — and 2025, when it soared 398.72%.
- Medicinova's Interest Expenses stood at $423279.0 in 2021, then jumped by 109.23% to $885646.0 in 2022, then jumped by 9313.11% to $83.4 million in 2023, then plunged by 99.4% to $500000.0 in 2024, then sank by 99.4% to $3000.0 in 2025.
- Business Quant data shows MNOV's Interest Expenses at $3000.0 in Q4 2025, $174427.0 in Q3 2025, and $327009.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 120,883.00 |
| Jun 30, 2026 | 120,883.00 |
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 174,427.00 |
| Sep 30, 2025 | 174,427.00 |
| Jun 30, 2025 | 327,009.00 |
| Jun 30, 2025 | 327,009.00 |
| Mar 31, 2025 | 388,336.00 |
| Mar 31, 2025 | 388,336.00 |
| Dec 31, 2024 | 500,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 70,720.00 |
| Sep 30, 2024 | 70,720.00 |
| Jun 30, 2024 | 557,027.00 |
| Jun 30, 2024 | 557,027.00 |
| Mar 31, 2024 | 77,866.00 |
| Mar 31, 2024 | 77,866.00 |
| Dec 31, 2023 | 83.37 Mn |
| Dec 31, 2023 | 83.37 Mn |